3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
6
Pain
4
Neoplasms
4
Agnosia
4
Chronic Pain
3
Pancreatic Neoplasms
2
Cancer Pain
2
Breast Neoplasms
2
Wounds and Injuries
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Ulcer
1
Thrombocythemia, Essential
1
Skin Ulcer
1
Signs and Symptoms
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pathologic Processes
1
Neurologic Manifestations
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
Radiosurgery
7
lenvatinib
5
Radiofrequency Ablation
5
Electroporation
5
Radiotherapy
3
Patient Navigation
3
Laparoscopy
3
Hepatectomy
3
Exercise
3
sintilimab
2
perflutren
2
Surgical Procedures, Operative
2
Standard of Care
2
Proton Therapy
2
Nutritional Status
2
Magnetic Resonance Spectroscopy
2
Liver Transplantation
2
Injections
2
Dextrins
2
Cryosurgery
2
Control Groups
2
Bupivacaine
2
Anesthesia, General
2
toripalimab
1
tislelizumab
1
seocalcitol
1
pembrolizumab
1
motexafin gadolinium
1
gadofosveset trisodium
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Neoplasms
×
Morphine
×
Clear all
NCT03715517
2026-02-05
SAFER-L
University of Manitoba
Phase NA
Recruiting
128 enrolled